As illustrated in Figure 3, primary tumor growth was severely impaired in the animals injected with cells expressing R103A-EPO, compared to the expected tumor growth in animals injected with negative control cells (P<0.001, table 3). The gene discussed is EPO; the disease is neoplasm.